BIOA
Bioage Labs
$4.99
−$0.11 (−2.16%)Oct 26, 2026
Key metrics
The numbers that frame BIOA today
- Market cap
- $229.03M
- Gross margin
- 100%
- EV / Sales
- 15.2
- ROIC
- -61.3%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $4.81
- 52wk High
- $25.96
Growth
Revenue and earnings trend for BIOA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BIOA
Is Bioage Labs a good buy?
No. Bioage Labs has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Bioage Labs is selling at a very high price.
What is the market capitalization of BIOA?
Bioage Labs's market capitalization is $229.03M.
What is the 52-week high for BIOA stock?
The 52-week high for Bioage Labs is $25.96. The current close of $4.99 is 80.8% below that high.
What is the 52-week low for BIOA stock?
The 52-week low for Bioage Labs is $4.81. The current close of $4.99 is 3.7% above that low.
Does BIOA stock pay dividends?
Bioage Labs does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BIOA?
Bioage Labs's Debt / Equity ratio is 0.01.